Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FREMANEZUMAB-VFRM Cause Liquid product physical issue? 15 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Liquid product physical issue have been filed in association with FREMANEZUMAB-VFRM. This represents 0.2% of all adverse event reports for FREMANEZUMAB-VFRM.

15
Reports of Liquid product physical issue with FREMANEZUMAB-VFRM
0.2%
of all FREMANEZUMAB-VFRM reports
0
Deaths
1
Hospitalizations

How Dangerous Is Liquid product physical issue From FREMANEZUMAB-VFRM?

Of the 15 reports, 1 (6.7%) required hospitalization.

Is Liquid product physical issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FREMANEZUMAB-VFRM. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does FREMANEZUMAB-VFRM Cause?

Accidental exposure to product (1,346) Injection site pain (1,153) Migraine (740) Drug ineffective (707) Injection site erythema (596) Device leakage (528) Headache (528) Injection site pruritus (462) Device malfunction (431) Injection site swelling (398)

What Other Drugs Cause Liquid product physical issue?

SOMATROPIN (679) EPINEPHRINE (618) ADALIMUMAB (404) USTEKINUMAB (226) INSULIN ASPART (211) TESTOSTERONE CYPIONATE (195) GUSELKUMAB (194) HUMAN IMMUNOGLOBULIN G (142) ERENUMAB-AOOE (95) BUDESONIDE (92)

Which FREMANEZUMAB-VFRM Alternatives Have Lower Liquid product physical issue Risk?

FREMANEZUMAB-VFRM vs FROVATRIPTAN FREMANEZUMAB-VFRM vs FRUCTOSE FREMANEZUMAB-VFRM vs FRUQUINTINIB FREMANEZUMAB-VFRM vs FULVESTRANT FREMANEZUMAB-VFRM vs FURAZOLIDONE

Related Pages

FREMANEZUMAB-VFRM Full Profile All Liquid product physical issue Reports All Drugs Causing Liquid product physical issue FREMANEZUMAB-VFRM Demographics